325 related articles for article (PubMed ID: 26633017)
1. Association between Thiopurine S-Methyltransferase Polymorphisms and Azathioprine-Induced Adverse Drug Reactions in Patients with Autoimmune Diseases: A Meta-Analysis.
Liu YP; Xu HQ; Li M; Yang X; Yu S; Fu WL; Huang Q
PLoS One; 2015; 10(12):e0144234. PubMed ID: 26633017
[TBL] [Abstract][Full Text] [Related]
2. Association between thiopurine S-methyltransferase polymorphisms and thiopurine-induced adverse drug reactions in patients with inflammatory bowel disease: a meta-analysis.
Liu YP; Wu HY; Yang X; Xu HQ; Li YC; Shi DC; Huang JF; Huang Q; Fu WL
PLoS One; 2015; 10(3):e0121745. PubMed ID: 25799415
[TBL] [Abstract][Full Text] [Related]
3. The impact of thiopurine-S-methyltransferase genotype on the adverse drug reactions to azathioprine in patients with inflammatory bowel diseases.
Hlavaty T; Batovsky M; Balakova D; Pav I; Celec P; Gregus M; Zakuciova M; Hlista M; Horakova M; Desatova B; Koller T; Toth J; Kadasi L; Huorka M;
Bratisl Lek Listy; 2013; 114(4):199-205. PubMed ID: 23514552
[TBL] [Abstract][Full Text] [Related]
4. Thiopurine S-methyltransferase polymorphisms and thiopurine toxicity in treatment of inflammatory bowel disease.
Dong XW; Zheng Q; Zhu MM; Tong JL; Ran ZH
World J Gastroenterol; 2010 Jul; 16(25):3187-95. PubMed ID: 20593505
[TBL] [Abstract][Full Text] [Related]
5. Combined evaluation of genotype and phenotype of thiopurine S-methyltransferase (TPMT) in the clinical management of patients in chronic therapy with azathioprine.
Rucci F; Cigoli MS; Marini V; Fucile C; Mattioli F; Robbiano L; Cavallari U; Scaglione F; Perno CF; Penco S; Marocchi A
Drug Metab Pers Ther; 2019 Mar; 34(1):. PubMed ID: 30840585
[TBL] [Abstract][Full Text] [Related]
6. Inosine triphosphate pyrophosphatase and thiopurine s-methyltransferase genotypes relationship to azathioprine-induced myelosuppression.
Zelinkova Z; Derijks LJ; Stokkers PC; Vogels EW; van Kampen AH; Curvers WL; Cohn D; van Deventer SJ; Hommes DW
Clin Gastroenterol Hepatol; 2006 Jan; 4(1):44-9. PubMed ID: 16431304
[TBL] [Abstract][Full Text] [Related]
7. Pharmacogenetic association with adverse drug reactions to azathioprine immunosuppressive therapy following liver transplantation.
Breen DP; Marinaki AM; Arenas M; Hayes PC
Liver Transpl; 2005 Jul; 11(7):826-833. PubMed ID: 15973722
[TBL] [Abstract][Full Text] [Related]
8. Genotype-Guided Prescription of Azathioprine Reduces the Incidence of Adverse Drug Reactions in TPMT Intermediate Metabolizers to a Similar Incidence as Normal Metabolizers.
Casajús A; Zubiaur P; Méndez M; Campodónico D; Gómez A; Navares-Gómez M; Villapalos-García G; Soria-Chacartegui P; Novalbos J; Román M; Mejía-Abril G; Ochoa D; Abad-Santos F
Adv Ther; 2022 Apr; 39(4):1743-1753. PubMed ID: 35192152
[TBL] [Abstract][Full Text] [Related]
9. Should thiopurine methyltransferase genotypes and phenotypes be measured before thiopurine therapy in patients with inflammatory bowel disease?
Fangbin Z; Xiang G; Minhu C; Liang D; Feng X; Min H; Pinjin H
Ther Drug Monit; 2012 Dec; 34(6):695-701. PubMed ID: 23149442
[TBL] [Abstract][Full Text] [Related]
10. Current use of pharmacogenetic testing: a national survey of thiopurine methyltransferase testing prior to azathioprine prescription.
Fargher EA; Tricker K; Newman W; Elliott R; Roberts SA; Shaffer JL; Bruce I; Payne K
J Clin Pharm Ther; 2007 Apr; 32(2):187-95. PubMed ID: 17381669
[TBL] [Abstract][Full Text] [Related]
11. A new thiopurine s-methyltransferase haplotype associated with intolerance to azathioprine.
Colleoni L; Kapetis D; Maggi L; Camera G; Canioni E; Cavalcante P; Kerlero de Rosbo N; Baggi F; Antozzi C; Confalonieri P; Mantegazza R; Bernasconi P
J Clin Pharmacol; 2013 Jan; 53(1):67-74. PubMed ID: 23400745
[TBL] [Abstract][Full Text] [Related]
12. Thiopurine methyltransferase gene polymorphisms and activity in Chinese patients with inflammatory bowel disease treated with azathioprine.
Zhu Q; Cao Q
Chin Med J (Engl); 2012 Oct; 125(20):3665-70. PubMed ID: 23075721
[TBL] [Abstract][Full Text] [Related]
13. TPMT and ITPA genetic variants in Lithuanian inflammatory bowel disease patients: Prevalence and azathioprine-related side effects.
Steponaitiene R; Kupcinskas J; Survilaite S; Varkalaite G; Jonaitis L; Kiudelis G; Denapiene G; Valantinas J; Skieceviciene J; Kupcinskas L
Adv Med Sci; 2016 Mar; 61(1):135-40. PubMed ID: 26674571
[TBL] [Abstract][Full Text] [Related]
14. Identification of thiopurine methyltransferase (TPMT) polymorphisms cannot predict myelosuppression in systemic lupus erythematosus patients taking azathioprine.
Naughton MA; Battaglia E; O'Brien S; Walport MJ; Botto M
Rheumatology (Oxford); 1999 Jul; 38(7):640-4. PubMed ID: 10461478
[TBL] [Abstract][Full Text] [Related]
15. The impact of thiopurine s-methyltransferase polymorphism on azathioprine-induced myelotoxicity in renal transplant recipients.
Kurzawski M; Dziewanowski K; Gawrońska-Szklarz B; Domański L; Droździk M
Ther Drug Monit; 2005 Aug; 27(4):435-41. PubMed ID: 16044099
[TBL] [Abstract][Full Text] [Related]
16. Thiopurine S-methyltransferase polymorphisms and the relationship between the mutant alleles and the adverse effects in systemic lupus erythematosus patients taking azathioprine.
Jun JB; Cho DY; Kang C; Bae SC
Clin Exp Rheumatol; 2005; 23(6):873-6. PubMed ID: 16396707
[TBL] [Abstract][Full Text] [Related]
17. A pragmatic randomized controlled trial of thiopurine methyltransferase genotyping prior to azathioprine treatment: the TARGET study.
Newman WG; Payne K; Tricker K; Roberts SA; Fargher E; Pushpakom S; Alder JE; Sidgwick GP; Payne D; Elliott RA; Heise M; Elles R; Ramsden SC; Andrews J; Houston JB; Qasim F; Shaffer J; Griffiths CE; Ray DW; Bruce I; Ollier WE;
Pharmacogenomics; 2011 Jun; 12(6):815-26. PubMed ID: 21692613
[TBL] [Abstract][Full Text] [Related]
18. Thiopurine methyltransferase genotype and the toxicity of azathioprine in Japanese.
Ishioka S; Hiyama K; Sato H; Yamanishi Y; McLeod HL; Kumagai K; Maeda H; Yamakido M
Intern Med; 1999 Dec; 38(12):944-7. PubMed ID: 10628931
[TBL] [Abstract][Full Text] [Related]
19. Plasma thiopurine S-methyltransferase levels and azathioprine-related adverse events in patients with Behçet's disease.
Emmungil H; Durusoy R; Kalfa M; Yargucu Zihni F; Özmen M; Keser G; Gücenmez S; Yilmaz Z; Aksu K
Clin Exp Rheumatol; 2015; 33(6 Suppl 94):S40-5. PubMed ID: 25936353
[TBL] [Abstract][Full Text] [Related]
20. Frequency of thiopurine methyltransferase mutation in patients of Mediterranean area with inflammatory bowel disease and autoimmune disorders.
Di Salvo A; Fabiano C; Mannara V; Dimarco M; Orlando A; Affronti M; Macaluso FS; Cottone M
Dig Liver Dis; 2016 Dec; 48(12):1506-1509. PubMed ID: 27665263
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]